These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6963097)

  • 1. Effect of administration of activated charcoal and fibre on absorption, excretion and steady state blood levels of digoxin and digitoxin. Evidence for intestinal secretion of the glycosides.
    Reissell P; Manninen V
    Acta Med Scand Suppl; 1982; 668():88-90. PubMed ID: 6963097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of cardiac glycoside drug interactions.
    Hooymans PM; Merkus FW
    Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapy.
    Kuhlmann J
    Arzneimittelforschung; 1982; 32(6):698-704. PubMed ID: 6889430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of activated charcoal on digoxin and digitoxin clearance.
    Park GD; Goldberg MJ; Spector R; Johnson GF; Feldman RD; Quee CK; Roberts P
    Drug Intell Clin Pharm; 1985 Dec; 19(12):937-41. PubMed ID: 4085353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin and digitoxin elimination in man by charcoal hemoperfusion.
    Gilfrich HJ; Okonek S; Manns M; Schuster CJ
    Klin Wochenschr; 1978 Dec; 56(23):1179-83. PubMed ID: 713438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intestinal absorption of cardiac glycosides in vitro and in vivo].
    Forth W; Furukawa E; Rummel W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(1):53-72. PubMed ID: 4237042
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of the intestinal absorption of cardiac glycosides by measurement of 3H-labelled glycosides in the portal venous blood and in the intestinal lymph of cats].
    Forth W; Furukawa E; Rummel W
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(4):406-19. PubMed ID: 4242055
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolism and intestinal absorption of cardiac glycosides].
    Lauterbach F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):26-39. PubMed ID: 4896199
    [No Abstract]   [Full Text] [Related]  

  • 9. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication.
    Caldwell JH; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2626-37. PubMed ID: 5129314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digitalis pharmacokinetics and therapy with respect to impaired renal function.
    Kramer P
    Klin Wochenschr; 1977 Jan; 55(1):1-11. PubMed ID: 319291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-related alterations in cardiac glycoside disposition.
    Ochs HR; Greenblatt DJ; Bodem G; Dengler HJ
    Clin Pharmacokinet; 1982; 7(5):434-51. PubMed ID: 6754209
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.
    Neuvonen PJ; Elfving SM; Elonen E
    Eur J Clin Pharmacol; 1978 May; 13(3):213-8. PubMed ID: 668776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies on the uptake of cardiac glycosides by the cell].
    Hüsten J; Ruiz-Torres A
    Verh Dtsch Ges Inn Med; 1969; 75():396-9. PubMed ID: 5400163
    [No Abstract]   [Full Text] [Related]  

  • 14. Absorption rates of some cardiac glycosides and portal blood flow.
    Haass A; Lüllmann H; Peters T
    Eur J Pharmacol; 1972 Sep; 19(3):366-70. PubMed ID: 4640860
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of cardiac glycosides studied in the isolated perfused guinea-pig liver.
    Kolenda KD; Lüllmann H; Peters T
    Br J Pharmacol; 1971 Apr; 41(4):661-73. PubMed ID: 5579464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the active or passive enteral resorption of cardiac glycosides].
    Mentz P; Witzleben H; Förster W
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):126-40. PubMed ID: 4674599
    [No Abstract]   [Full Text] [Related]  

  • 17. [Direct determination of intestinal absorption of tritium-labelled cardiac glycosides by measurement of portal and arterial concentrations and volume of portal vein flow in guinea pigs].
    Haass A; Peters T
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):343. PubMed ID: 4253785
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics, bioavailability and serum levels of cardiac glycosides.
    Smith TW
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):43A-50A. PubMed ID: 3921586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of probenecid on the in vitro absorption of cardiac glycosides.
    Damm KH; Woermann C
    Eur J Pharmacol; 1974 Sep; 28(1):157-63. PubMed ID: 4430319
    [No Abstract]   [Full Text] [Related]  

  • 20. [Distribution and biotransformation of various cardiac glycosides].
    Lüllmann H; Peters T; Seiler KU
    Dtsch Med Wochenschr; 1971 Jun; 96(23):1018-21. PubMed ID: 4932862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.